Get Started Sign In

The da Vinci Xi: Does evidence support a price premium?

The da Vinci Surgical System is a surgeon-controlled, minimally invasive robotic platform used to perform a range of complex procedures. The da Vinci Xi was introduced in 2014 to address perceived design shortcomings of its predecessor, the da Vinci Si. However, these improvements come at a higher cost.

Download this article to:

  • Learn what issues the da Vinci Xi was designed to address
  • Explore how the Xi’s modifications impact clinical and operational outcomes
  • Discover whether these outcomes justify the Xi’s price tag
Complimentary Access to Lumere's Solutions
Tackle unwarranted variation across drugs and devices. 
No thanks. Our value analysis teams and P&T committees are not currently working to cut costs or improve outcomes.